[HORMONE EXCRETIONS AND BLOOD COAGULATION FACTORS DURING ORAL GESTAGEN-ESTROGEN THERAPY (EVALUATION OF THE RISK OF THROMBOPHLEBITIS)].
D000305:Adrenal Cortex Hormones; D001778:Blood Coagulation Disorders; D001779:Blood Coagulation Factors; D001780:Blood Coagulation Tests; D003276:Contraceptives, Oral; D004358:Drug Therapy; D004967:Estrogens; D004997:Ethinyl Estradiol; D005260:Female; D006801:Humans; D009640:Norethindrone; D011372:Progestins; D013924:Thrombophlebitis; D014116:Toxicology; D014556:Urine
D000305:Adrenal Cortex Hormones; D001779:Blood Coagulation Factors; D003276:Contraceptives, Oral; D004967:Estrogens; D011372:Progestins; D004997:Ethinyl Estradiol; D009640:Norethindrone
ADRENAL CORTEX HORMONES; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION TESTS; DRUG THERAPY; ETHINYL ESTRADIOL; NORETHINDRONE; THROMBOPHLEBITIS; TOXICOLOGIC REPORT; URINE
HORMONAUSSCHEIDUNGEN UND BLUTGERINNUNGSFAKTOREN UNTER ORALER GESTAGEN-OSTROGEN-BEHANDLUNG (BEURTEILUNG DES THROMBOPHLEBITISRISIKOS)